- Home
- ELVN vs PTA Comparison
ELVN vs PTA Comparison
Compare ELVN & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PTA
- Stock Information
- Founded
- ELVN 2016
- PTA 2020
- Country
- ELVN United States
- PTA United States
- Employees
- ELVN N/A
- PTA N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PTA Trusts Except Educational Religious and Charitable
- Sector
- ELVN Health Care
- PTA Finance
- Exchange
- ELVN Nasdaq
- PTA Nasdaq
- Market Cap
- ELVN 1.2B
- PTA 1.1B
- IPO Year
- ELVN 2020
- PTA N/A
- Fundamental
- Price
- ELVN $19.32
- PTA $19.97
- Analyst Decision
- ELVN Strong Buy
- PTA
- Analyst Count
- ELVN 5
- PTA 0
- Target Price
- ELVN $41.20
- PTA N/A
- AVG Volume (30 Days)
- ELVN 410.5K
- PTA 159.2K
- Earning Date
- ELVN 08-12-2025
- PTA 01-01-0001
- Dividend Yield
- ELVN N/A
- PTA 8.31%
- EPS Growth
- ELVN N/A
- PTA N/A
- EPS
- ELVN N/A
- PTA N/A
- Revenue
- ELVN N/A
- PTA N/A
- Revenue This Year
- ELVN N/A
- PTA N/A
- Revenue Next Year
- ELVN N/A
- PTA N/A
- P/E Ratio
- ELVN N/A
- PTA N/A
- Revenue Growth
- ELVN N/A
- PTA N/A
- 52 Week Low
- ELVN $13.30
- PTA $15.84
- 52 Week High
- ELVN $30.03
- PTA $19.67
- Technical
- Relative Strength Index (RSI)
- ELVN 40.65
- PTA 56.22
- Support Level
- ELVN $21.25
- PTA $19.75
- Resistance Level
- ELVN $22.83
- PTA $20.01
- Average True Range (ATR)
- ELVN 1.42
- PTA 0.18
- MACD
- ELVN -0.35
- PTA -0.01
- Stochastic Oscillator
- ELVN 5.60
- PTA 73.47
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.